|
|
|
Insider
Information: |
Ueno Ryuji |
Relationship: |
10% Owner |
City: |
Bethesda |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
10% Owner |
2015-03-31 |
0 |
2018-02-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2012-11-28 |
4 |
AS |
$5.02 |
$140,619 |
I/I |
(28,028) |
26,233,400 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-01-08 |
4 |
AS |
$5.00 |
$146,626 |
I/I |
(29,307) |
25,516,194 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-08-06 |
4 |
AS |
$6.21 |
$149,671 |
I/I |
(24,100) |
25,016,188 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
|
2014-04-21 |
4 |
AS |
$6.71 |
$159,800 |
I/I |
(23,800) |
23,128,502 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-07-08 |
4 |
AS |
$6.48 |
$182,450 |
I/I |
(28,162) |
25,103,412 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
|
2014-04-17 |
4 |
AS |
$6.74 |
$192,079 |
I/I |
(28,500) |
23,152,302 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
|
2014-08-06 |
4 |
AS |
$6.32 |
$193,000 |
I/I |
(30,523) |
22,527,763 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-03-04 |
4 |
AS |
$5.04 |
$193,752 |
I/I |
(38,462) |
25,439,270 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
|
2014-04-24 |
4 |
AS |
$6.77 |
$194,351 |
I/I |
(28,700) |
22,985,702 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-02-19 |
4 |
AS |
$5.14 |
$197,729 |
I/I |
(38,462) |
25,477,732 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2012-10-01 |
4 |
S |
$5.15 |
$198,194 |
I/I |
(38,450) |
26,362,352 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-01-22 |
4 |
AS |
$5.21 |
$200,252 |
I/I |
(38,462) |
25,584,830 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-02-04 |
4 |
AS |
$5.22 |
$200,729 |
I/I |
(38,462) |
25,546,368 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2012-12-12 |
4 |
AS |
$5.28 |
$203,141 |
I/I |
(38,462) |
26,170,909 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-03-18 |
4 |
AS |
$5.28 |
$203,218 |
I/I |
(38,462) |
25,400,808 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-09-03 |
4 |
AS |
$5.59 |
$214,887 |
I/I |
(38,462) |
24,939,264 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2012-10-15 |
4 |
S |
$5.86 |
$225,518 |
I/I |
(38,462) |
26,323,890 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-08-19 |
4 |
AS |
$6.04 |
$232,257 |
I/I |
(38,462) |
24,977,726 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-04-01 |
4 |
AS |
$6.25 |
$240,476 |
I/I |
(38,462) |
25,362,346 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-04-15 |
4 |
AS |
$6.87 |
$246,300 |
I/I |
(35,862) |
25,326,484 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-06-24 |
4 |
AS |
$6.61 |
$254,234 |
I/I |
(38,462) |
25,131,574 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
|
2014-04-23 |
4 |
AS |
$6.73 |
$260,478 |
I/I |
(38,700) |
23,014,402 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
|
2014-08-04 |
4 |
AS |
$6.03 |
$279,856 |
I/I |
(46,393) |
22,642,529 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-06-10 |
4 |
AS |
$7.29 |
$280,384 |
I/I |
(38,462) |
25,170,036 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
|
2013-05-28 |
4 |
AS |
$8.79 |
$338,193 |
I/I |
(38,462) |
25,208,498 |
0 |
- |
|
91 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|